HB 93 – Require Naloxone Scripts with Opioid Scripts

HB 93 – Require Naloxone Scripts with Opioid Scripts

Primary House Sponsors: Rep. Wayne Sasser (R-Cabarrus, Rowan, Stanly); Rep. Chris Humphrey (R-Lenoir, Pitt); Rep. Timothy Moffitt (R-Henderson); Rep. Gale Adcock (D-Wake)

Summary

This bill requires practitioners to co-prescribe an opioid antagonist when one or more of the following conditions are present:

  • The prescription dosage is 50 or more morphine milligram equivalents of an opioid medication per day.
  • A Schedule II controlled substance is prescribed concurrently with a prescription for benzodiazepine.
  • The patient present with an increase risk for overdose, as evidence by, but not limited to (1) a patient with a history of overdose; (2) a patient with a history of substance use disorder, or (3) a patient at risk for returning to a high dosage of a Schedule II controlled substance to which the patient is no longer tolerant.

This bill also requires practitioners to provide education on overdose prevent and opioid antagonist use to all patients receiving prescriptions pursuant to the new requirements or to the patient’s parent, guardian, or person standing in loco parentis.

The failure to comply with the bill’s requirements would subject practitioners to potential administrative sanctions as deemed appropriate by their licensing board.

Movement

Filed – 2/16/2021

Referred to the following House Committees on 2/17/2021:

-Insurance

-Health

-Rules, Calendar, Operations

Re-referred to House Health Committee on 3/10/2021

 
 

More Posts in Current Legislative Session

 
 

Share this Post



 
 
 

1 Comment

  • Ankit Agarwal

    Thanks for highlighting this bill! While we are all well aware of the opioid crisis/epidemic, and believe in the lifesaving power of naloxone (I used to carry it around with me when I previously lived in an area with an especially high rate of overdose death and have of course prescribed it), we also know that some patients (particularly cancer patients) are under-treated for their pain. We have seen this with decreasing opioid prescriptions for patients in the cancer setting: https://pubmed.ncbi.nlm.nih.gov/32469405/. Mandating naloxone will further stigmatize the use of opioid pain medications when appropriate and make my job treating patients with cancer related pain more difficult. Thank you to the NCMS for your work advocating against this bill